MOBI · Mobia Medical, Inc. · Metrics
$10.01
-0.24 (-2.34%)
At close · Sep 11
Going-concern doubt
— cleared Aug 11, 2026
The latest filing states the doubt was alleviated.
“In prior reporting periods, the Company concluded that recurring operating losses, negative cash flows from operations, and future expenditures raised substantial doubt about its ability to continue as a going concern. In May 2026, the Company completed its IPO and received net proceeds of approximately $134.0 million. As a result of the additional liquidity provided by the completed IPO, management concluded that the existing cash and cash equivalents are sufficient to fund its operations and meet its obligations for at least one year from the date these condensed unaudited interim financial statements are issued. Accordingly, management concluded that the conditions and events described above do not raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 11, 2026
Market Cap
$333.24M
Shares
33.29M
MOBI metrics
33 of 115 screener metrics currently available.
Market overview
2 metricsShare price
$10.01
Market cap
$333.24M
Price action
20 metricsPrice change (1W)
-11.9%
Price change (30D)
-12.2%
Price change (3M)
-16.8%
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
77.3%
Annualized volatility (3M)
86.6%
Beta
—
RSI (14D)
39.6
Price vs SMA 50
-12.3%
Price vs SMA 200
—
Avg volume (3M)
149,592
Relative volume
0.7
Average dollar volume
$1.84M
Company
3 metricsSector
Healthcare
Industry
Medical Devices
Shares outstanding
33.29M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
2.0
reciprocal yield 50.6%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-14
Profitability
9 metricsGross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+102.4%
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+2,164.0%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
—
Return on assets
—
Debt / equity
—
Current ratio
13.3
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
12.8
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$177.09M
Latest balance sheet
Cash & equivalents
$177.09M
Total assets
$195.28M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
3 metrics13F filers
42
13F filer change QoQ
+42
Institutional ownership
25.7%
Short interest
3 metricsShort interest
1.1%
Latest settlement · 2.6 days to cover
Days to cover
2.6d
Short-squeeze score
30 / 100
Insider activity
2 metricsNet insider buying (90D)
$995,696
Insider-sentiment score
87 / 100
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1489993
CUSIP
60705V103
13F (30d)
33 filings
33 filers
Visit website
Investor relations